Associated Papers
Development and Performance Validation of a Comprehensive Liquid Biopsy Genotyping Panel for Pan-cancer Analysis.
Lim S et al.
Annals of Laboratory Medicine, 2025
40888113 (PubMed )
Supplement: alm-46-2-210-supple.pdf
The impact of C216T and hot spot mutations of the TERT promoter on the clinicopathologic characteristics and S100A10 expression in papillary thyroid carcinoma: a comparative study.
Li P et al.
Diagnostic Pathology, 2025
Identification of h-TERT Promoter Mutations in Germline DNA from North Indian Lung Carcinoma Patients.
Prasad R et al.
Indian Journal of Clinical Biochemistry : Ijcb, 2023
Prospective Analysis of TERT Promoter Mutations in Papillary Thyroid Carcinoma at a Single Institution.
Choi YS et al.
Journal of Clinical Medicine, 2021
Identification of a missense variant in SPDL1 associated with idiopathic pulmonary fibrosis.
Dhindsa RS et al.
Communications Biology, 2021
33758299 (PubMed )
Supplement: 42003_2021_1910_MOESM4_ESM.xlsx › ExWAS_p_0.05
Highly prevalent BRAF V600E and low-frequency TERT promoter mutations underlie papillary thyroid carcinoma in Koreans.
Kim SY et al.
Journal of Pathology and Translational Medicine, 2020
Recurrent TERT promoter mutations in non-small cell lung cancers.
Ma X et al.
Lung Cancer (amsterdam, Netherlands), 2014
Low frequency of TERT promoter somatic mutation in 313 sporadic esophageal squamous cell carcinomas.
Zhao Y et al.
International Journal of Cancer, 2014
Select a paper to view details